Ravnskov · BMJ open 2016 · systematic review of cohort studies · n=19 studies (30 cohorts, 68,094 participants)

Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review.

Cited 358 times in the scientific literature.

Level 3 - non-randomized controlled study

Systematic review of observational cohort studies

PubMed 27292972 · doi:10.1136/bmjopen-2015-010401 · record verified 2026-08-27

What was done

Authors conducted a systematic review searching PubMed for cohort studies examining low-density lipoprotein cholesterol (LDL-C) as a risk factor for all-cause and/or cardiovascular (CV) mortality in community-dwelling adults aged 60 years and older.

What was found

The review identified 19 cohort studies covering 30 distinct cohorts and 68,094 individuals. All-cause mortality was assessed in 28 cohorts and CV mortality in 9 cohorts. An inverse association between LDL-C and all-cause mortality was present in 16 cohorts (statistically significant in 14), representing 92% of participants assessed for this outcome; the remaining cohorts found no association. For CV mortality, 2 cohorts reported significantly higher mortality in the lowest LDL-C quartile, whereas 7 cohorts found no association. Pooled effect sizes and confidence intervals were not reported in the abstract.

Why it matters

These findings challenge the assumption that elevated LDL-C consistently increases mortality risk across all age groups, raising questions about guidelines recommending routine pharmacological LDL-lowering in elderly populations.

Limits

The underlying evidence is entirely observational, precluding causal inference. The abstract notes only a PubMed search (omitting other databases) and provides qualitative cohort counts rather than pooled meta-analytic risk estimates. Observational studies in elderly populations are also prone to reverse causation and residual confounding, such as terminal illness, frailty, or malnutrition lowering lipid levels prior to death, as well as unmeasured statin use.

Cited by